Chiron Capital Management’s Exelixis EXEL Stock Holding History

Chiron Capital Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-800	Closed	-$20K	–	191
2020 Q3	$20K	Buy	+800	New	+$18.7K	0.02%	225

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Chiron Capital Management's EXEL Position: Q4 2020 in Review

Chiron Capital Management sold out of Exelixis (EXEL) in Q4 2020, closing a stake of 800 shares — an estimated $20K sold.

Chiron Capital Management first reported a position in EXEL in Q3 2020 and held it in 1 quarter. The position peaked at $20K in Q3 2020. 351 funds tracked by Wall St. Rank hold EXEL as of Q4 2020.

Chiron Capital Management reported no remaining Exelixis position as of Q4 2020 after selling out during the quarter.
Chiron Capital Management sold 800 Exelixis shares in Q4 2020, an estimated $20K.
Chiron Capital Management first reported a position in Exelixis in Q3 2020 and held it in 1 quarter.
Chiron Capital Management's Exelixis position peaked at $20K in Q3 2020.
351 funds tracked by Wall St. Rank held Exelixis as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.